Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3646853017 | Product containing selective adhesion molecule inhibitor (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3746593013 | Selective adhesion molecule inhibitor-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing selective adhesion molecule inhibitor (product) | Is a | Medicinal product acting as immunosuppressant (product) | false | Inferred relationship | Some | ||
| Product containing selective adhesion molecule inhibitor (product) | Has active ingredient | Selective adhesion molecule inhibitor | true | Inferred relationship | Some | 1 | |
| Product containing selective adhesion molecule inhibitor (product) | Is a | Product containing immunomodulator (product) | false | Inferred relationship | Some | ||
| Product containing selective adhesion molecule inhibitor (product) | Is a | Medicinal product categorized by disposition (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing alpha-4 integrin receptor antagonist (product) | Is a | True | Product containing selective adhesion molecule inhibitor (product) | Inferred relationship | Some | |
| Product containing crizanlizumab (medicinal product) | Is a | True | Product containing selective adhesion molecule inhibitor (product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR